Jade Biosciences, Inc. · NASDAQ:JBIO
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Jade Biosciences, Inc. (Schedule 13G)
Event Apr 28, 2025 · Filed May 5, 2025
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Jade Biosciences, Inc., 3,220,369 shares, as a passive investor on Apr 28, 2025. Filed May 5, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 3,220,369
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 9.90% | 3,220,369 |
| VHCP Co-Investment Holdings III, LLC | 9.90% | 3,220,369 |
| Venrock Healthcare Capital Partners EG, L.P. | 9.90% | 3,220,369 |
| VHCP Management III, LLC | 9.90% | 3,220,369 |
| VHCP Management EG, LLC | 9.90% | 3,220,369 |
| Nimish Shah | 9.90% | 3,220,369 |
| Bong Y Koh | 9.90% | 3,220,369 |
Source
Related
- Jade Biosciences, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Feb 17, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026